Literature DB >> 20654603

Establishment of reference intervals for soluble ST2 from a United States population.

Jun Lu1, James V Snider, David G Grenache.   

Abstract

BACKGROUND: Soluble ST2 (sST2) is a protein in the interleukin-1 receptor family secreted by myocytes in response to mechanical strain. Elevated sST2 is strongly prognostic in patients with heart failure.
METHODS: sST2 was measured using the Presage ST2 ELISA. Evaluation included imprecision, linearity, recovery, analytical sensitivity, limit of quantification, stability, and sample type comparisons. Gender-specific reference intervals were established from 245 male and 245 female serum specimens.
RESULTS: At sST2 concentrations of 11.6, 26.9, and 88.0 ng/mL, the within-day CV was 7.6, 2.4, and 3.8%, respectively and the total CV was 11.5, 14.0, and 6.3%, respectively. The assay was linear over a concentration range of 2.8-161.1 ng/mL (y=0.95x+2.25; R(2)=0.997; Sy.x=3.03). The limit of quantification was 3.3 ng/mL. sST2 was stable for 2 days at room temperature, 10days at 4 °C, and 30 days at -20 °C. Concentrations of sST2 were significantly higher in males compared to females (24.9 vs. 16.9 ng/mL; p<0.0001) but were not correlated by age in either gender (r=-0.07; p=0.14). Reference intervals for sST2 were determined to be 8.6-49.3 and 7.2-33.5 ng/mL for males and females, respectively.
CONCLUSION: The Presage ST2 ELISA had acceptable performance characteristics for quantifying sST2 in serum or plasma. The assay is precise and linear over a wide sST2 concentration range and can measure low sST2 concentrations. Concentrations of sST2 are unaffected by age but are higher in males compared to females. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20654603     DOI: 10.1016/j.cca.2010.07.014

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  25 in total

Review 1.  The Confounding Effects of Non-cardiac Pathologies on the Interpretation of Cardiac Biomarkers.

Authors:  Marin Nishimura; Alison Brann; Kay-Won Chang; Alan S Maisel
Journal:  Curr Heart Fail Rep       Date:  2018-08

2.  Cocaine use is associated with a higher prevalence of elevated ST2 concentrations.

Authors:  Xander M R van Wijk; Eric Vittinghoff; Alan H B Wu; Kara L Lynch; Elise D Riley
Journal:  Clin Biochem       Date:  2017-04-23       Impact factor: 3.281

3.  Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.

Authors:  Michael R Zile; Pardeep S Jhund; Catalin F Baicu; Brian L Claggett; Burkert Pieske; Adriaan A Voors; Margaret F Prescott; Victor Shi; Martin Lefkowitz; John J V McMurray; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2016-01       Impact factor: 8.790

4.  Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab.

Authors:  Heloisa Sawaya; Igal A Sebag; Juan Carlos Plana; James L Januzzi; Bonnie Ky; Timothy C Tan; Victor Cohen; Jose Banchs; Joseph R Carver; Susan E Wiegers; Randolph P Martin; Michael H Picard; Robert E Gerszten; Elkan F Halpern; Jonathan Passeri; Irene Kuter; Marielle Scherrer-Crosbie
Journal:  Circ Cardiovasc Imaging       Date:  2012-06-28       Impact factor: 7.792

5.  Association of soluble ST2 with functional capacity in outpatients with heart failure.

Authors:  O Yucel; I Gul; A Zararsiz; O Demirpence; H Yucel; Z Cinar; A Zorlu; M B Yilmaz
Journal:  Herz       Date:  2017-06-26       Impact factor: 1.443

Review 6.  Sexual Dimorphism in Cardiovascular Biomarkers: Clinical and Research Implications.

Authors:  Emily S Lau; Aleksandra Binek; Sarah J Parker; Svati H Shah; Markella V Zanni; Jennifer E Van Eyk; Jennifer E Ho
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 23.213

7.  Are soluble ST2 levels in the picogram or nanogram range in serum of healthy subjects/disease patients?

Authors:  Rohit Saluja
Journal:  J Korean Med Sci       Date:  2014-01       Impact factor: 2.153

8.  Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study.

Authors:  Erin E Coglianese; Martin G Larson; Ramachandran S Vasan; Jennifer E Ho; Anahita Ghorbani; Elizabeth L McCabe; Susan Cheng; Michael G Fradley; Dana Kretschman; Wei Gao; George O'Connor; Thomas J Wang; James L Januzzi
Journal:  Clin Chem       Date:  2012-10-11       Impact factor: 8.327

9.  Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes.

Authors:  G Michael Felker; Mona Fiuzat; Vivian Thompson; Linda K Shaw; Megan L Neely; Kirkwood F Adams; David J Whellan; Mark P Donahue; Tariq Ahmad; Dalane W Kitzman; Ileana L Piña; Faiez Zannad; William E Kraus; Christopher M O'Connor
Journal:  Circ Heart Fail       Date:  2013-10-08       Impact factor: 8.790

10.  Soluble ST2 has a prognostic role in patients with suspected sepsis.

Authors:  Mina Hur; Hanah Kim; Hyun Jeong Kim; Hyun Suk Yang; Laura Magrini; Rossella Marino; Patrizia Cardelli; Salvatore Di Somma
Journal:  Ann Lab Med       Date:  2015-11       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.